Adamed Pharma’s Strategic Partnership with Organon in Italy

The Italian branch office of Adamed Pharma has signed a marketing and distribution agreement with Organon Italia, strengthening its position on the Italian market.

This strategic partnership provides Adamed’s products with even broader reach to doctors and patients in Italy, enhancing the brand’s presence in this market.

The seven Adamed-branded products will complement Organon’s portfolio of drugs for chronic diseases, particularly cardiovascular disease, which is still the leading cause of mortality in Italy. Adamed’s mission, i.e. to respond to the key challenges of modern medicine, including the fight against chronic diseases, will thus be even more strongly addressed in Italy.

Adamed’s cooperation with Organon Italia is another milestone in the process of building Adamed’s position in international markets as part of the company’s internationalisation strategy.